1. Home
  2. GNFT vs BSII Comparison

GNFT vs BSII Comparison

Compare GNFT & BSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • BSII
  • Stock Information
  • Founded
  • GNFT 1999
  • BSII 2024
  • Country
  • GNFT France
  • BSII Hong Kong
  • Employees
  • GNFT N/A
  • BSII N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • BSII
  • Sector
  • GNFT Health Care
  • BSII
  • Exchange
  • GNFT Nasdaq
  • BSII Nasdaq
  • Market Cap
  • GNFT 172.2M
  • BSII 189.9M
  • IPO Year
  • GNFT 2019
  • BSII 2024
  • Fundamental
  • Price
  • GNFT $3.70
  • BSII $9.94
  • Analyst Decision
  • GNFT Strong Buy
  • BSII
  • Analyst Count
  • GNFT 1
  • BSII 0
  • Target Price
  • GNFT $13.00
  • BSII N/A
  • AVG Volume (30 Days)
  • GNFT 3.8K
  • BSII 50.0
  • Earning Date
  • GNFT 09-19-2024
  • BSII 01-01-0001
  • Dividend Yield
  • GNFT N/A
  • BSII N/A
  • EPS Growth
  • GNFT N/A
  • BSII N/A
  • EPS
  • GNFT 0.47
  • BSII N/A
  • Revenue
  • GNFT $86,225,222.00
  • BSII N/A
  • Revenue This Year
  • GNFT $145.20
  • BSII N/A
  • Revenue Next Year
  • GNFT N/A
  • BSII N/A
  • P/E Ratio
  • GNFT $7.47
  • BSII N/A
  • Revenue Growth
  • GNFT 175.45
  • BSII N/A
  • 52 Week Low
  • GNFT $3.35
  • BSII $9.86
  • 52 Week High
  • GNFT $6.42
  • BSII $10.30
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 47.76
  • BSII N/A
  • Support Level
  • GNFT $3.35
  • BSII N/A
  • Resistance Level
  • GNFT $3.66
  • BSII N/A
  • Average True Range (ATR)
  • GNFT 0.11
  • BSII 0.00
  • MACD
  • GNFT 0.04
  • BSII 0.00
  • Stochastic Oscillator
  • GNFT 63.64
  • BSII 0.00

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About BSII Black Spade Acquisition II Co Class A Ordinary Share

Black Spade Acquisition II Co is a blank check company.

Share on Social Networks: